Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
324
324 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- FMC-376Phase 22 trials
Frontier Medicines Corporation · Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor
- IBB0979Phase 22 trials
SUNHO(China)BioPharmaceutical CO., Ltd. · Small Cell Lung Cancer, Advanced Malignant Tumors
- IDP-121Phase 22 trials
IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- ImzokitugBMS-986340Phase 22 trials
Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer
- KB707Phase 22 trials
Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV
- KCBT-1083BEBT-109Phase 22 trials
BeBetter Med Inc · Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
- KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials
InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer
- LM103 TILsPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer
- LS301-ITPhase 22 trials
Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS
- M1774TuvusertibPhase 22 trials
EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer
- NelistotugGSK6097608Phase 22 trials
GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck
- NelmastobartPhase 22 trials
STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer
- ODM-212Phase 22 trials
Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer
- PD-L1 monoclonal antibodyPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Non-Small Cell Lung Cancer, Advanced Malignant Solid Tumor
- PF-07104091ovarian, SCLCPhase 22 trials
Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer
- quaratusugene ozeplasmidREQORSAPhase 22 trials
Genprex, Inc. · Carcinoma, Non-Small Cell Lung, Small Cell Lung Cancer Extensive Stage
- QuavonlimabMK-1308Phase 22 trials
Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer
- RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials
Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc
- RC108Phase 22 trials
RemeGen Co., Ltd. · Non-Small Cell Lung Cancer, Digestive Cancer
- RDEABSK141-Recommended Expansion, S095018 RecommendedPhase 22 trials
Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult, Non-small Cell Lung Cancer (NSCLC)
- S095029Phase 22 trials
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer
- silevertinibBDTX-1535Phase 22 trials
Black Diamond Therapeutics, Inc. · Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM
- SKB500Phase 22 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Esophageal Squamous Cell Carcinoma, Small Cell Lung Cancer
- SPGL008Phase 22 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · NMIBC, Non Small Cell Lung Cancer
- Sutetinib MaleatePhase 22 trials
Teligene US · Non-small Cell Lung Cancer
- TCC1727Phase 22 trials
Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)
- TNO155Phase 22 trials
Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors
- ABT-101DBPR112Phase 21 trial
Anbogen Therapeutics, Inc. · Advanced Solid Tumor, Non Small Cell Lung Cancer, HER2 Mutations
- adebeliizumabPhase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer
- AFNT-211Phase 21 trial
Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer
- ALK202Phase 21 trial
Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer)
- Alomnertinib MesilatePhase 21 trial
Shanghai Hengrui Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer
- and CarboplatinPhase 21 trial
CrystalGenomics, Inc. · Non Squamous Non Small Cell Lung Cancer
- ANS014004Phase 21 trial
Beijing Pearl Biotechnology Limited Liability Company · Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer
- ANS02Phase 21 trial
Avistone Biotechnology Co., Ltd. · Non-Small Cell Lung Cancer
- AP203Phase 21 trial
AP Biosciences Inc. · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)
- ATX-295Phase 21 trial
Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer
- AU-007Phase 21 trial
Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma
- AZD2811Phase 21 trial
AstraZeneca · Small-Cell Lung Cancer
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- AZD7789Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer
- AZD8205Phase 21 trial
AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer
- BBT-207Phase 21 trial
Bridge Biotherapeutics, Inc. · EGFR Mutant Advanced Non-Small Cell Lung Cancer
- BH-30643Phase 21 trial
BlossomHill Therapeutics · NSCLC (Advanced Non-small Cell Lung Cancer)
- BI-1910Phase 21 trial
BioInvent International AB · Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma
- BLU-924SAR449336Phase 21 trial
Blueprint Medicines Corporation · Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms
- BMS-986012Phase 21 trial
Bristol Myers Squibb · Extensive-stage Small Cell Lung Cancer
- BMS-986523Phase 21 trial
Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- BMS-986525Phase 21 trial
Bristol Myers Squibb · Relapsed/Refractory Small Cell Lung Cancer
- BNT116Phase 21 trial
Regeneron · Advanced Non-Small Cell Lung Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.